Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
1.988 Leser
Artikel bewerten:
(2)

Delisting of Securities of SmileDirectClub, Inc.; Bellerophon Therapeutics, Inc.; Elys Game Technology; Athersys, Inc.; Borqs Technologies; ContraFect Corporation; CohBar, Inc.; AgileThought, Inc.; Fat Projects Acquisition; Evelo Biosciences ...

NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of SmileDirectClub, Inc. SmileDirectClub, Inc.'s securities were suspended on October 4, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Bellerophon Therapeutics, Inc. Bellerophon Therapeutics, Inc.'s securities were suspended on October 16, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Elys Game Technology, Corp. Elys Game Technology, Corp.'s securities were suspended on October 17, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Athersys, Inc. Athersys, Inc.'s securities were suspended on October 18, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of Borqs Technologies, Inc. Borqs Technologies, Inc.'s securities were suspended on October 27, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of ContraFect Corporation. ContraFect Corporation's securities were suspended on November 9, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of CohBar, Inc. CohBar, Inc.'s securities were suspended on November 19, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A common stock and warrants of AgileThought, Inc. AgileThought, Inc.'s securities were suspended on November 24, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A ordinary shares, warrants, and unit of Fat Projects Acquisition Corp. Fat Projects Acquisition Corp.'s securities were suspended on December 1, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Evelo Biosciences, Inc. Evelo Biosciences, Inc.'s securities were suspended on December 12, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of Troika Media Group, Inc. Troika Media Group, Inc.'s securities were suspended on December 18, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Impel Pharmaceuticals Inc. Impel Pharmaceuticals Inc.'s securities were suspended on December 18, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.'s securities were suspended on December 19, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of Near Intelligence, Inc. Near Intelligence, Inc.'s securities were suspended on December 19, 2023, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.


© 2023 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.